Particle.news

Download on the App Store

Canada Clears Apple Watch Hypertension Notifications

Health Canada's licence sets the stage for a Canadian launch pending Apple’s software activation plus any remaining provincial sign‑offs.

Overview

  • Health Canada granted the medical device licence on September 25 under Licence No. 114026, and Apple confirmed it has received the clearance.
  • The feature is not yet available to users in Canada and will require a regional software rollout and, in some cases, provincial approvals before it can be enabled.
  • Hypertension Notifications screen for patterns of chronically high blood pressure by passively analyzing optical heart‑sensor data over 30 days and do not display a blood‑pressure reading.
  • Apple positions the alerts as non‑diagnostic guidance to take arm‑cuff measurements—typically over seven days—and consult a clinician if a notification appears.
  • Eligibility requires an Apple Watch Series 9 or Ultra 2 (or newer) on watchOS 26 with an iPhone 11 or later, and users must be 22 or older, not pregnant, and without a prior hypertension diagnosis; Apple cites training data from over 100,000 participants and validation in a study of more than 2,000 people, with the feature already live in many regions including the U.S.